@rebeccaphd.bsky.social
VP, Global Commercial Strategy Lymphoma, Leukemia and Cell Therapy, Johnson & Johnson Innovative Medicine. Posts are my own.
Great time at #ASH24 learning about cutting edge science, meeting incredible people and being reminded of the power of social media in healthcare.
December 10, 2024 at 7:56 PM
Great time at #ASH24 learning about cutting edge science, meeting incredible people and being reminded of the power of social media in healthcare.
Reposted
Great to see the Bleximenib data being presented here at #ASH24! More progress is needed in AML! #MyCompany
December 7, 2024 at 11:05 PM
Great to see the Bleximenib data being presented here at #ASH24! More progress is needed in AML! #MyCompany